162 related articles for article (PubMed ID: 21204893)
21. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
22. Depletion of CD4+CD25+CD127lo regulatory T cells does not increase allergen-driven T cell activation.
Skrindo I; Farkas L; Kvale EO; Johansen FE; Jahnsen FL
Clin Exp Allergy; 2008 Nov; 38(11):1752-9. PubMed ID: 18681851
[TBL] [Abstract][Full Text] [Related]
23. Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.
Hueman MT; Stojadinovic A; Storrer CE; Foley RJ; Gurney JM; Shriver CD; Ponniah S; Peoples GE
Breast Cancer Res Treat; 2006 Jul; 98(1):17-29. PubMed ID: 16758122
[TBL] [Abstract][Full Text] [Related]
24. Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer.
Saha A; Chatterjee SK
Scand J Immunol; 2010 Feb; 71(2):70-82. PubMed ID: 20384858
[TBL] [Abstract][Full Text] [Related]
25. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
26. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
27. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
28. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
30. [Advances in cellular immunotherapy for malignant melanoma].
López M; Escobar A; Alfaro J; Fodor M; Larrondo M; Ferrada C; Salazar-Onfray F
Rev Med Chil; 2004 Sep; 132(9):1115-26. PubMed ID: 15543770
[TBL] [Abstract][Full Text] [Related]
31. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
33. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
34. [Effect of apoptosis of CD4+ CD25+ regulatory T lymphocytes on polarization of helper T lymphocytes and potential interventional influence of Xuebijing injection in septic rats].
Dai XG; Yao YM; Ai YH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):135-8. PubMed ID: 19278580
[TBL] [Abstract][Full Text] [Related]
35. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.
Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426
[TBL] [Abstract][Full Text] [Related]
37. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
[TBL] [Abstract][Full Text] [Related]
38. Frequency of circulating Tregs with demethylated FOXP3 intron 1 in melanoma patients receiving tumor vaccines and potentially Treg-depleting agents.
de Vries IJ; Castelli C; Huygens C; Jacobs JF; Stockis J; Schuler-Thurner B; Adema GJ; Punt CJ; Rivoltini L; Schuler G; Coulie PG; Lucas S
Clin Cancer Res; 2011 Feb; 17(4):841-8. PubMed ID: 21177412
[TBL] [Abstract][Full Text] [Related]
39. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
[TBL] [Abstract][Full Text] [Related]
40. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]